Suppr超能文献

维拉帕米单独及联合利尿剂治疗老年原发性高血压的降压疗效

[Hypotensive efficacy of verapamil alone and in combination with a diuretic in the treatment of essential hypertension in geriatric patients].

作者信息

Latini R, Pierandrei G, Achilli L, Lombi V, D'Amico F

出版信息

G Ital Cardiol. 1987 Feb;17(2):144-8.

PMID:3301500
Abstract

To evaluate the hypotensive efficacy of Verapamil alone and combined with diuretic, in the treatment of essential hypertension in elderly patients, we studied 54 patients, mean age 67.2 +/- 4.7 years, with essential hypertension, I-II WHO class. After a two-week wash-out from previous hypotensive therapies, patients were divided, at random, into three groups and, in double-blind conditions; they were treated as follows: the first group was treated with Verapamil (V) slow-release 240 mg/die, the second group with Chlorthalidone (C) 50 mg/die and the third group with the combination of Verapamil slow-release 240 mg/die and Chlorthalidone 50 mg/die (V + C). In the first group, the therapy (V) statistically reduced (p less than 0.001) either PAS or PAD values in supine position, (respectively -13 +/- 9 mmHg and -12 +/- 4 mmHg) and PAS-PAD values in upright position (respectively -16 +/- 3 mmHg and -10 +/- 3 mmHg). In the group treated with C, a statistically significant reduction (p less than 0.001) of PAS (-12 +/- 3 mmHg in supine position and -16 +/- 3 mmHg in upright position) and of PAD (-11 +/- 5 in supine and -9 +/- 4 mmHg in upright position). In the third group, V + C treatment induced a statistically bigger reduction of PAS and PAD (p less than 0.001) than that of the other two groups either in supine (-24 +/- 3 and -21 +/- 5 mmHg, respectively) or in upright position (-26 +/- 4 and -20 +/- 5 mmHg, respectively). Three patients interrupted the therapy for scarse compliance (I-II group).(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

为评估维拉帕米单用及联合利尿剂治疗老年原发性高血压的降压效果,我们研究了54例年龄平均为67.2±4.7岁的WHO I-II级原发性高血压患者。在停用先前降压治疗两周后,患者被随机分为三组,并采用双盲法进行如下治疗:第一组服用维拉帕米(V)缓释片240mg/日,第二组服用氯噻酮(C)50mg/日,第三组服用维拉帕米缓释片240mg/日联合氯噻酮50mg/日(V+C)。第一组治疗(V)使仰卧位收缩压(PAS)或舒张压(PAD)值有统计学意义地降低(p<0.001),分别降低了-13±9mmHg和-12±4mmHg,立位PAS-PAD值分别降低了-16±3mmHg和-10±3mmHg。在服用C组,PAS(仰卧位-12±3mmHg,立位-16±3mmHg)和PAD(仰卧位-11±5mmHg,立位-9±4mmHg)有统计学意义地显著降低(p<0.001)。在第三组,V+C治疗使仰卧位(分别为-24±3和-21±5mmHg)和立位(分别为-26±4和-20±5mmHg)的PAS和PAD降低幅度在统计学上比其他两组更大(p<0.001)。三名患者因依从性差中断治疗(I-II组)。(摘要截断于250字)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验